α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease

AIM: To investigate the impact of inflammatory bowel disease (IBD) on α2-Heremans-Schmid Glycoprotein (AHSG/fetuin A) and potential associations with disease and patient characteristics. METHODS: AHSG serum levels were determined in treatment-naïve newly-diagnosed patients, 96 with ulcerative coliti...

Descripción completa

Detalles Bibliográficos
Autores principales: Manolakis, Anastassios C, Christodoulidis, Gregory, Kapsoritakis, Andreas N, Georgoulias, Panagiotis, Tiaka, Elisavet K, Oikonomou, Kostas, Valotassiou, Varvara J, Potamianos, Spyros P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291848/
https://www.ncbi.nlm.nih.gov/pubmed/28210079
http://dx.doi.org/10.3748/wjg.v23.i3.437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291848/
https://www.ncbi.nlm.nih.gov/pubmed/28210079
http://dx.doi.org/10.3748/wjg.v23.i3.437

Ejemplares similares